A-C Test Listings

Test Code: 10018

CPT Code(s): 87015, 87207

Breast Plus Panel without BRCA (TP53, STK11, PTEN, CDH1, PALB2)

Test Code: 92586

CPT Code(s): 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479

Clinical Significance: CDH1, PALB2, PTEN, STK11 and TP53 are tumor suppressor genes, where inherited mutations significantly increase breast cancer risk. Sequence analysis and deletion/duplication analysis of these five genes can explain an additional 3% to 4.5% of hereditary breast cancers.

Test Code: 92573

CPT Code(s): 81162

Includes: If the Interpretation Summary is not one of the following three results: Positive for a known Pathogenic Mutation; Positive for a likely Pathogenic Mutation; Positive for a likely Pathogenic Mutation and a variant with unknown significance, then TP53, PTEN, CDH1, STK11, and PALB2 will be performed at an additional charge (CPT code(s) 81321, 81323, 81404, 81405 (x2), 81406 (x2), 81479).

Test Code: 19108

CPT Code(s): 80048

Includes: Glucose, Urea Nitrogen (BUN), Creatinine, BUN/Creatinine Ratio, Sodium, Potassium, Chloride, Carbon Dioxide, Calcium

Methodology: Ion Selective Electrode (ISE) • Spectrophotometry (SP)

Clinical Significance: See individual tests

Test Code: 7210

CPT Code(s): 85004, 85014, 85018, 85041, 85048

Clinical Significance: A complete blood count is used as a screening test for various disease states including anemia, leukemia and inflammatory processes.

Test Code: 7008

CPT Code(s): 85014, 85018, 85041, 85048 (HCPCS: G0307)

Clinical Significance: A complete blood count used as a screening test for various disease states to include: Anemia, leukemia and inflammatory processes.

Includes: WBC, RBC, Hemoglobin, Hematocrit, MCV, MCH, MCHC, RDW

Test Code: 6399